Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D.

Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D.

Minor histocompatibility Ags elicit cell-mediated immune responses and graft rejection in individuals receiving MHC-matched tissues. H60 represents a dominant Ag that elicits a strong CTL response in C57BL/6 mice immunized against BALB.B. An 8-aa peptide in the H60 protein is presented by H-2K(b) an...

Full description

Bibliographic Details
Main Authors:	Cerwenka, A, O'Callaghan, C, Hamerman, J, Yadav, R, Ajayi, W, Roopenian, D, Joyce, S, Lanier, L
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
by: O'Callaghan, C, et al.
Published: (2001)

NKG2D
by: O'Callaghan, C
Published: (2009)

Regulation of ligands for the activating receptor NKG2D.
by: Mistry, A, et al.
Published: (2007)

Structural and energetic aspects of multispecific immune recognition by NKG2D.
by: O'Callaghan, C, et al.
Published: (2003)

Cellular metabolism controls NKG2D-dependent cellular immunogenicity
by: McCarthy, M, et al.
Published: (2013)

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
by: Eun Young Choi, et al.
Published: (2020-06-01)

Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
by: O'Callaghan, C
Published: (2000)

Editorial: Emerging Concepts on the NKG2D Receptor-Ligand Axis in Health and Diseases
by: Nadia Guerra, et al.
Published: (2020-04-01)

NKG2H-Expressing T Cells Negatively Regulate Immune Responses
by: Daniela Dukovska, et al.
Published: (2018-03-01)

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
by: Braud, V, et al.
Published: (1998)

Involvement of Male-Specific Minor Histocompatibility Antigen H-Y in Epidermal Equivalent Allograft Rejection
by: Marie-Josée Beaulieu, et al.
Published: (1998-01-01)

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
by: Michaëlsson, J, et al.
Published: (2002)

Minor Histocompatibility Antigen-Specific T Cells
by: Corinne Summers, et al.
Published: (2020-06-01)

Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
by: McCarthy, M, et al.
Published: (2019)

A role for NKG2D in NK cell-mediated resistance to poxvirus disease.
by: Min Fang, et al.
Published: (2008-02-01)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01)

Cooperation across the histocompatibility barrier: H2d T cells primed to antigen in an H-2d environment can cooperate with H-2k B cells.
by: Waldmann, H, et al.
Published: (1976)

Comparative analysis of minor histocompatibility antigens genotyping methods
by: A. S. Vdovin, et al.
Published: (2016-08-01)

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
by: Natasja Nielsen, et al.
Published: (2012-01-01)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
by: Polina Kaidun, et al.
Published: (2023-08-01)

Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations.
by: Antoun, A, et al.
Published: (2010)

Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys
by: Peter B. Rupert, et al.
Published: (2024-04-01)

The human minor histocompatibility antigen 1 is a RhoGAP.
by: Bart-Jan de Kreuk, et al.
Published: (2013-01-01)

NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
by: Di Yang, et al.
Published: (2017-04-01)

MLC and CMC reactivity and specificity of idiotype-specific lymphoid cells enriched for histocompatibility (H-2) antigens.
by: Folks, T, et al.
Published: (1979)

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
by: Mutis, T, et al.
Published: (1999)

CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
by: Söderström, K, et al.
Published: (1997)

Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
by: Zhuanyun Du, et al.
Published: (2022-06-01)

Minor histocompatibility antigens HA‐8 and PANE1 in the TUNISIAN population
by: Rahma Said, et al.
Published: (2022-11-01)

Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide.
by: Vessey, S, et al.
Published: (1997)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
by: Fabrizio Antonangeli, et al.
Published: (2017-11-01)

Screening and Identification of an H-2Kb-Restricted CTL Epitope within the Glycoprotein of Hantaan Virus
by: Rui-xue Ma, et al.
Published: (2016-11-01)

Mechanisms of NKG2D ligand regulation
by: McCarthy, M, et al.
Published: (2013)

Corrigendum: The Role of NKG2D in Vitiligo
by: Lourdes Plaza-Rojas, et al.
Published: (2021-06-01)

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas
by: Hannes Vietzen, et al.
Published: (2023-06-01)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
by: Tobias Zöller, et al.
Published: (2018-03-01)

Leveraging NKG2D Ligands in Immuno-Oncology
by: Mercedes Beatriz Fuertes, et al.
Published: (2021-07-01)

The Paradoxical Role of NKG2D in Cancer Immunity
by: Sam Sheppard, et al.
Published: (2018-08-01)

Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.
by: Capraru, D, et al.
Published: (2008)

Autosomal minor histocompatibility antigens; How genetic variants create diversity in immune targets
by: Marieke eGriffioen, et al.
Published: (2016-03-01)